Revenues of KalVista Pharmaceuticals, Inc. from 30 Apr 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
KalVista Pharmaceuticals, Inc. quarterly and annual Revenues in USD history and change rate from 30 Apr 2016 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Revenues for the quarter ending 30 Sep 2025 was $13,700,000.
  • KalVista Pharmaceuticals, Inc. annual Revenues for 2023 was $50,000,000.
  • KalVista Pharmaceuticals, Inc. annual Revenues for 2017 was $8,394,000, a 458% increase from 2016.
  • KalVista Pharmaceuticals, Inc. annual Revenues for 2016 was $1,504,000, a 29% decline from 2015.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,700,000 +$13,700,000 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,400,000 +$1,400,000 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2026 Q1
Q4 2024 $50,000,000 01 Nov 2024 30 Nov 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $0 01 May 2024 31 Jul 2024 10-Q 11 Sep 2025 2026 Q1
Q1 2018 $8,394,000 $4,840,000 +$4,726,000 +4146% 01 Feb 2018 30 Apr 2018 10-K 30 Jul 2018 2018 FY
Q4 2017 $3,668,000 $2,331,000 +$2,083,000 +840% 01 Nov 2017 31 Jan 2018 10-K 30 Jul 2018 2018 FY
Q3 2017 $1,585,000 $1,127,000 +$930,000 +472% 01 Aug 2017 31 Oct 2017 10-K 30 Jul 2018 2018 FY
Q2 2017 $655,000 $96,000 -$879,000 -90% 01 May 2017 31 Jul 2017 10-K 30 Jul 2018 2018 FY
Q1 2017 $1,534,000 $114,000 01 Feb 2017 30 Apr 2017 10-K 30 Jul 2018 2018 FY
Q4 2016 $248,000 01 Nov 2016 31 Jan 2017 10-K 30 Jul 2018 2018 FY
Q3 2016 $197,000 01 Aug 2016 31 Oct 2016 10-K 30 Jul 2018 2018 FY
Q2 2016 $975,000 01 May 2016 31 Jul 2016 10-K 30 Jul 2018 2018 FY

KalVista Pharmaceuticals, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $50,000,000 01 May 2023 30 Apr 2024 10-Q 11 Sep 2025 2026 Q1
2017 $8,394,000 +$6,890,000 +458% 01 May 2017 30 Apr 2018 10-K 30 Jul 2018 2018 FY
2016 $1,504,000 -$629,000 -29% 01 May 2016 30 Apr 2017 10-K 30 Jul 2018 2018 FY
2015 $2,133,000 01 May 2015 30 Apr 2016 10-K 30 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.